Accessibility navigation

Endocannabinoids in neuroendopsychology: multiphasic control of mitochondrial function

Nunn, A., Guy, G. and Bell, J. D. (2012) Endocannabinoids in neuroendopsychology: multiphasic control of mitochondrial function. Philsophical Transactions of the Royal Society B, 367 (1607). pp. 3342-3352. ISSN 1471-2970

Text - Published Version
· Available under License Creative Commons Attribution.
· Please see our End User Agreement before downloading.


It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

To link to this item DOI: 10.1098/rstb.2011.0393


The endocannabinoid system (ECS) is a construct based on the discovery of receptors that are modulated by the plant compound tetrahydrocannabinol and the subsequent identification of a family of nascent ligands, the 'endocannabinoids'. The function of the ECS is thus defined by modulation of these receptors-in particular, by two of the best-described ligands (2-arachidonyl glycerol and anandamide), and by their metabolic pathways. Endocannabinoids are released by cell stress, and promote both cell survival and death according to concentration. The ECS appears to shift the immune system towards a type 2 response, while maintaining a positive energy balance and reducing anxiety. It may therefore be important in resolution of injury and inflammation. Data suggest that the ECS could potentially modulate mitochondrial function by several different pathways; this may help explain its actions in the central nervous system. Dose-related control of mitochondrial function could therefore provide an insight into its role in health and disease, and why it might have its own pathology, and possibly, new therapeutic directions.

Item Type:Article
Divisions:No Reading authors. Back catalogue items
ID Code:35366
Publisher:Royal Society


Downloads per month over past year

University Staff: Request a correction | Centaur Editors: Update this record

Page navigation